Healthcare News
New treatment for psoriatic arthritis shows promising results in early trial
A new treatment for a debilitating inflammatory condition which affects joints and skin has shown promising early results in an international clinical trial of more than 200 patients worldwide. Results from the trial showed that patients with psoriatic arthritis who were treated with a new nanobody drug called sonelokimab, achieved much greater improvements in joint pain, swelling, and skin symptoms than patients who received a placebo.
Cell therapy represents ‘fascinating new chapter’ in rheumatology
The use of cell therapy in rheumatology is likely to expand considerably in the coming years, according to a presenter at the Association of Women in Rheumatology Annual Conference.
Inflammatory Polyarthropathy vs. Types of Arthritis
Rheumatoid arthritis is a type of inflammatory arthritis, but there are several arthritis conditions that occur due to an inflammatory condition. When at least five joints are affected, RA also is an inflammatory polyarthritis.
The many ways that AI enters rheumatology
Artificial intelligence (AI) is entering the mainstream. The term encompasses a wide variety of machines that can learn from data, identify patterns, and make decisions. But how can it be used to support health care? EULAR—The European Alliance of Associations for Rheumatology—has picked a number of abstracts for its 2025 congress in Barcelona that showcase how AI is influencing different areas in rheumatology—from diagnosis through to monitoring, risk prediction, and patient communication.
Patients with knee osteoarthritis who receive metformin exhibit improved pain
Patients with knee osteoarthritis who received metformin demonstrated significant reductions in knee pain and increased weight loss at 6 months vs. placebo, according to data published in JAMA.
